Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma

被引:23
作者
Espinet, B
Solé, F
Woessner, S
Bosch, F
Florensa, L
Campo, E
Costa, D
Lloveras, E
Vilà, RM
Besses, C
Montserrat, E
Sans-Sabrafen, J
机构
[1] Hosp Esperanca, Lab Referencia Catalunya, Unitat Hematol 1973, Lab Citol Hematol, Barcelona 08024, Spain
[2] Hosp Clin & Prov Barcelona, Unitat Hematopatol, Barcelona, Spain
[3] Hosp Clin & Prov Barcelona, Serv Citogenet, Barcelona, Spain
关键词
D O I
10.1016/S0165-4608(98)00228-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have studied 13 cases of histologically confirmed mantle cell lymphomas (MCL) combining cytological-immunological features with conventional cytogenetics and in situ hybridization (ISH) techniques. Peripheral blood smears and lymph node biopsies expressed the typical mantle zone pattern with a B-cell phenotype. Most of the cases (11 of 13) had lymphomatous cells in the peripheral blood. Chromosome analysis was carried out on lymphoid cells from peripheral blood and/or lymph node biopsies. Phytohemagglutinin (PHA) and phorbol 12-myristate 13 acetate (TPA) were used as mitogens. Biotin-labeled libraries of whole chromosomes implicated in complex karyotypes were used to improve their interpretation. Clonal chromosome abnormalities were found in 10 of 13 patients (77%); 7 of these had a complex abnormality. The most frequent recurrent structural abnormalities were: t(11;14)(q13;q32), involvement of chromosome 1 (der[1], del[1], dup[1]), chromosome 2 (del[2], der[2]), chromosome 9 (der[9], -9), chromosome 13 (add[13], t[13q]), and chromosome 17 (add[17], der[17], t[17q]). The most frequent numerical abnormalities it ere monosomy 21 and loss of the Y chromosome. (C) Elsevier Science Inc., 1999. All rights reserved.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 45 条
[1]   Mantle cell lymphoma: A clinicopathologic study of 80 cases [J].
Argatoff, LH ;
Connors, JM ;
Klasa, RJ ;
Horsman, DE ;
Gascoyne, RD .
BLOOD, 1997, 89 (06) :2067-2078
[2]  
BENNETT MH, 1974, LANCET, V2, P405
[3]  
BERARD CW, 1978, CANCER-AM CANCER SOC, V42, P911, DOI 10.1002/1097-0142(197808)42:2+<911::AID-CNCR2820420713>3.0.CO
[4]  
2-G
[5]  
BOSCH F, 1994, BLOOD, V84, P2726
[6]   TRANSLOCATION T(11-14)(Q13-Q32) IN CHRONIC LYMPHOID DISORDERS [J].
BRITOBABAPULLE, V ;
ELLIS, J ;
MATUTES, E ;
OSCIER, D ;
KHOKHAR, T ;
MACLENNAN, K ;
CATOVSKY, D .
GENES CHROMOSOMES & CANCER, 1992, 5 (02) :158-165
[7]  
DEBOER CJ, 1993, CANCER RES, V53, P4148
[8]   Mantle cell lymphomas: Characteristics, natural history and prognostic factors of 45 cases [J].
Decaudin, D ;
Bosq, J ;
Munck, JN ;
Bayle, C ;
Koscielny, S ;
Boudjemaa, S ;
Bennaceur, A ;
Venuat, AM ;
Naccache, P ;
Bendahmane, B ;
Ribrag, V ;
Carde, P ;
Pico, JL ;
Hayat, M .
LEUKEMIA & LYMPHOMA, 1997, 26 (5-6) :539-&
[9]  
GERARDMARCHANT R, 1974, LANCET, V2, P405
[10]  
HARRIS NL, 1994, BLOOD, V84, P1361